CpG island methylation status and mutation analysis of the RBI gene essential promoter region and protein-binding pocket domain in nervous system tumours

British Journal of Cancer

Volumn 88, Issue 1, 2003, Pages 109-114

  Gonzalez Gomez, P ^a   Bello, M J ^a   Alonso, M E ^a   Arjona, D ^a   Lomas, J ^a   De Campos, J M ^b   Isla, A ^a   Rey, J A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

CpG island; Hypermethylation; Mutation; Nervous system tumours; RBI gene

Indexed keywords

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; EPENDYMOMA; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NERVOUS SYSTEM TUMOR; NEUROFIBROSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; RBI GENE;

CPG ISLANDS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; NERVOUS SYSTEM NEOPLASMS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN;

EID: 0037434432     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600737     Document Type: Article

References (45)

1. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A, Rey JA (1994) Molecular analysis of genomic abnormalities in human gliomas. Cancer Genet Cytogenet 73: 122-129
3. Bookstein R, Rio P, Madrepeira SA, Homg F, Allred C, Grizzle WE, Lee WH (1990a) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87: 7762-7766
4. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H (1990b) Supression of tumourigenicity of human prostate carcinoma cells by replacing a mutated RB1 gene. Science 247: 712-715
5. Borg A, Zhang QX, Alm P, Olsson H, Sellberg G (1992) The retinoblastoma gene in breast cancer: allelic loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991-2994
6. Buchkovich K, Duffy LA, Harlow E (1989) The retinoblastoma gene is phosphorylated during specific phases of the cell cycle. Cell 58: 1097-1105
7. Burns KL, Ueki K, Jhung SL, Koh J, Louis DN (1998) Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas. J Neuropathol Exp Neurol 57: 122-130
8. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323: 1457-1462
9. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ (1996) Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56: 1142-1145
10. Cryns VL, Thor A, Xu HJ, Hu SX, Wierman ME, Vickery AL, Benedict WF, Arnold A (1994) Loss of retinoblastoma tumour-suppressor gene in parathyroid carcinoma. N Engl J Med 330: 757-761
11. Delgado S, Gomez M, Bird A, Antequera F (1998) Initiation of DNA replication at CpG islands in mammalian chromosomes. EMBO J 17: 2426-2435
12. Dong S-M, Pang JC-S, Poon W-S, Hu J, Yo K-F, Chang AR, Ng H-K (2001) Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumours. J Neuropathol Exp Neurol 60: 808-816
13. Esteller M, Herman JG (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196: 1-7
14. Friend SH, Bernards R, Rogelji S, Weinberg RA, Rapaport JM, Alberts DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646
15. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL, Brambilla C (1994) Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinoma. Int J Cancer 58: 818-824
16. Greger V, Debus N, Lohmann D, Hopping W, Passarge E, Horsthemke B (1994) Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94: 491-496
17. Hensel CH, Hsieh C-L, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL, Lee W-H, Lee EY-HP (1990) Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res 50: 3067-3072
18. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36: 714-721
19. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
20. Hogg A, Bia B, Onadim Z, Cowell K (1993) Molecular mechanisms of oncogenetic mutations in tumours from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci USA 90: 7351-7355
21. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13: 1065-1072
22. Ishikawa J, Xu H-J, Yandell DW, Maeda S, Kamidono S, Benedict WF, Takahashi R (1991) Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51: 5736-5743
23. Jones PA (1996) DNA methylation errors and cancer. Cancer Res 56: q2463-2467
24. Jones PA, Laird PW (1999) Cancer epigenetic comes of age. Nat Genet 21: 163-167
25. Kleihues P, Burger PC, Scheitauer BW (1993) Histological typing of tumours of the nervous system. WHO International Histological Classification of Tumours, 2nd edn. Berlin: Springer-Verlag
26. Lee WH, Shew JY, Hong F, Sery T, Donoso LA, Young LJ, Bookstein R, Lee EYHP (1987) The retinoblastoma susceptibility gene product is a nuclear phosphoprotein associated with DNA binding activity. Nature 329: 642-645
27. Logothetis CJ, Xu HJ, Ro JY, Xu SX, Sahin A, Ordonez N, Benedict WF (1992) Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84: 1256-1261
28. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92: 6289-6293
29. Mori N, Yokota J, Akiyama T, Sameshima Y, Okamoto A, Mizoguchi H, Toyoshima K, Sugimura T, Terada M (1990) Variable mutation of the RB gene in small-cell lung carcinoma. Oncogene 11: 1713-1717
30. Nakamura M, Konishi N, Hiasa Y, Tsunoda S, Fukushima Y, Tsuzuki T, Takemura K, Aoki H, Kobitsu K, Sakaki Y (1996) Immunohistochemical detection of CDKN2, retinoblastoma and p53 gene products in primary astrocytic tumours. Int J Oncol 8: 889-893
31. Nakamura M, Yonekawa Y, Kleihues P, Ohgaki H (2001) Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest 81: 77-82
32. Ohtani-Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD, Sakai T (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumour-suppressor gene. Oncogene 8: 1063-1067
33. Rey JA, Bello MJ, Jimenez-Lara A, Vaquero J, Kusak ME, de Campos JM, Sarasa JL, Pestaña A (1992) Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51: 703-706
34. Sakai T, Ohtami N, McGee TL, Robbins PD, Dryja TP (1991) Oncogenic germ-line mutations in SpI and ATF sites in the human retinoblastoma gene. Nature 353: 83-86
35. INK4 gene inactivation by hypermethylaton in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 6: 4307-4313
36. Simpson DJ, Magnay J, Bicknell JE, Barkan AL, McNicol AM, Clayton RN, Farrell WE (1999) Chromosome 13q deletion mapping in pituitary tumours: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. Cancer Res 59: 2703-2709
37. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE (2000) Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 60: 1211-1216
38. Stirzaker C, Millar S, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ (1997) Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumours. Cancer Res 57: 2229-2237
39. Trudel M, Mulligna L, Cavenee W, Margolese R, Cote J, Gariepy G (1992) Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 23: 1388-1394
40. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M (1996) Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Cancer 78: 287-293
41. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (1996) CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56: 150-153
42. Watanabe T, Yokoo H, Yokoo M, Yonekawa Y, Kleihues P, Ohgaki H (2001) Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas. J Neuropathol Exp Neurol 60: 1181-1189
43. Xu HJ, Xu SX, Cagle PT, Moore GE, Benedict WF (1991) Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 51: 2735-2739
44. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF (1993) Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumour progression. Int J Cancer 53: 781-784
45. Yandell DW, Campbell TA, Dayton SH, Petersen R, Walton D, Little JB, McConkie-Rosell A, Buckley EG, Dryja TP (1989) Oncogeneic point mutations in the human retinoblastoma gene: their application to genetic counselling. N Engl J Med 21: 1689-1695